We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

With a market cap of $258 billion, Merck & Co., Inc. (MRK) is a global healthcare company, operating in the pharmaceutical and animal health sectors. Based in Rahway, New Jersey, Merck develops ...

Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's ...

Shares of Merck & Co. Inc. MRK slipped 0.48% to $103.73 Tuesday, on what proved to be an all-around mixed trading session for ...

Yale spinout Modifi agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to market ...

In a report released yesterday, Mohit Bansal from Wells Fargo assigned a Hold rating on Merck & Company (MRK – Research Report), ...

Despite a strong Q2, Merck's stock fell due to concerns over Gardasil and Winrevair. See more on MRK stock and its ...

On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $103.98 which represents a decrease of $-1.90 or -1.79% from the prior close of $105.88. The stock opened at $106.49 and touched ...

2024 EPS Guidance: $7.72 to $7.77. Merck & Co Inc (NYSE:MRK) reported a 4% increase in revenues for the quarter, or 7% on a constant currency basis, driven by strong performance in key areas like ...

Merck & Co reported stronger-than-expected quarterly earnings thanks to rising Keytruda sales. However, Gardasil's weak ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...